| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 43.567 | 141.496 | 163.645 | 148.813 | 114.941 | 127.340 | 131.527 | 141.254 | 145.657 |
| Total Income - EUR | - | 43.567 | 141.498 | 163.790 | 152.728 | 118.942 | 129.563 | 146.799 | 142.308 | 145.853 |
| Total Expenses - EUR | - | 8.555 | 37.869 | 92.310 | 102.878 | 66.951 | 65.061 | 96.074 | 103.596 | 110.468 |
| Gross Profit/Loss - EUR | - | 35.012 | 103.629 | 71.480 | 49.850 | 51.990 | 64.502 | 50.725 | 38.712 | 35.385 |
| Net Profit/Loss - EUR | - | 34.576 | 101.565 | 69.839 | 48.362 | 51.018 | 63.254 | 49.373 | 37.394 | 31.099 |
| Employees | - | 2 | 2 | 3 | 2 | 2 | 2 | 3 | 3 | 3 |
Check the financial reports for the company - Med-Dopa S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 189 | 12.154 | 31.619 | 51.948 | 32.273 | 18.497 | 71.444 | 48.035 | 29.509 |
| Current Assets | - | 35.154 | 111.392 | 73.593 | 40.511 | 53.623 | 48.160 | 43.413 | 32.249 | 34.135 |
| Inventories | - | 176 | 0 | 0 | 295 | 0 | 0 | 0 | 0 | 915 |
| Receivables | - | 8.100 | 43.929 | 68.460 | 39.300 | 53.036 | 35.136 | 36.328 | 29.790 | 32.913 |
| Cash | - | 26.878 | 67.463 | 5.134 | 916 | 587 | 13.023 | 7.085 | 2.460 | 307 |
| Shareholders Funds | - | 34.632 | 101.817 | 69.906 | 48.425 | 51.080 | 63.315 | 49.434 | 37.454 | 31.159 |
| Social Capital | - | 56 | 55 | 54 | 53 | 52 | 51 | 51 | 51 | 50 |
| Debts | - | 711 | 22.457 | 35.768 | 44.242 | 34.816 | 3.816 | 65.423 | 42.965 | 32.589 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Med-Dopa S.r.l.